We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Modified Botulinum Toxin Targets Nerve Cells and Reverses Paralysis in Mice

News   Jan 11, 2021 | Original story from Boston Children's Hospital

 
Modified Botulinum Toxin Targets Nerve Cells and Reverses Paralysis in Mice

The toxin-based delivery platform consists of the modified botulinum toxin at upper left (protease domain in gold, translocation domain in blue, and receptor-binding domain in purple) and the nanobody (the pink tag). When this nanobody-toxin fusion protein binds to the receptor (cyan) on the neuron surface, the cell takes it in through the process of endocytosis, corralling the fusion protein inside a vesicle (light green circle). The toxin's protease domain, carrying the nanobody, then crosses into the interior of the cell. Credit: Sicai Zhang/Dong Lab, Boston Children's Hospital

 
 
Advertisement
 

RELATED ARTICLES

Large-Scale Study Identifies Genes That Increase the Risk of Bedwetting

News

A team of scientists from Aarhus University (AU) and Aarhus University Hospital (AUH) has identified genetic variants that increase the likelihood of nocturnal enuresis (NE) – commonly referred to as bedwetting.

READ MORE

Sleep Problems and Stress Can Lead to Concussion-Like Symptoms

News

A new study suggests that a lot of people might be going through life with symptoms that resemble concussion - a finding supporting researchers' argument that athletes recovering from a brain injury should be assessed and treated on a highly individualized basis.

READ MORE

The Brain Benefits of a Bilingual Upbringing Last Into Adulthood

News

New research has found that growing up in a bilingual home can provide unexpected cognitive benefits later in life.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE